SURPASS-IPF: Study Design of a Phase 3, Head-to-Head Trial of Deupirfenidone Compared to Pirfenidone... ATS International Conference. 2026. Maher TM, et al. [Poster]
Previous
Previous
Deep Learning-based HRCT Assessment of Baseline Disease Severity in the Deupirfenidone ELEVATE IPF Trial...American Thoracic Society (ATS) International Conference. 2026. Craster A, et al. [Poster]
Next
Next